Investing.com - Vericel Corp Ord reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Vericel Corp Ord announced earnings per share of $0.14 on revenue of $38.6M. Analysts polled by Investing.com anticipated EPS of $-0.11 on revenue of $40.16M.
Vericel Corp Ord shares are down 16.73% from the beginning of the year and are trading at $22.01 , down-from-52-week-high.
Vericel Corp Ord shares lost 4.51% in pre-market trade the report.
Vericel Corp Ord follows other major Healthcare sector earnings this month
Vericel Corp Ord's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar